List of Excipients in API emtricitabine and tenofovir disoproxil fumarate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing emtricitabine and tenofovir disoproxil fumarate
Excipients in ANDA-approved (generic) drugs containing emtricitabine and tenofovir disoproxil fumarate
Detailed excipient profiles for emtricitabine and tenofovir disoproxil fumarate
Excipient focus: ALUMINUM OXIDE
emtricitabine and tenofovir disoproxil fumarate drug variants containing ALUMINUM OXIDE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS LACTOSE
emtricitabine and tenofovir disoproxil fumarate drug variants containing ANHYDROUS LACTOSE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM STEARATE
emtricitabine and tenofovir disoproxil fumarate drug variants containing CALCIUM STEARATE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing CALCIUM STEARATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
emtricitabine and tenofovir disoproxil fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
emtricitabine and tenofovir disoproxil fumarate drug variants containing CROSCARMELLOSE SODIUM
emtricitabine and tenofovir disoproxil fumarate drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
emtricitabine and tenofovir disoproxil fumarate drug variants containing CROSPOVIDONE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing CROSPOVIDONE
Excipient focus: FD&C BLUE NO. 1
emtricitabine and tenofovir disoproxil fumarate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | emtricitabine and tenofovir disoproxil fumarate | 0378-1930 |
| >Company | >Ingredient | >NDC |
emtricitabine and tenofovir disoproxil fumarate drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
emtricitabine and tenofovir disoproxil fumarate drug variants containing FD&C BLUE NO. 2
emtricitabine and tenofovir disoproxil fumarate drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
emtricitabine and tenofovir disoproxil fumarate drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FERRIC OXIDE YELLOW
emtricitabine and tenofovir disoproxil fumarate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | emtricitabine and tenofovir disoproxil fumarate | 0378-1930 |
| >Company | >Ingredient | >NDC |
emtricitabine and tenofovir disoproxil fumarate drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: GLYCERYL CAPRYLATE/CAPRATE
emtricitabine and tenofovir disoproxil fumarate drug variants containing GLYCERYL CAPRYLATE/CAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| DIRECT RX | emtricitabine and tenofovir disoproxil fumarate | 72189-227 |
| >Company | >Ingredient | >NDC |
emtricitabine and tenofovir disoproxil fumarate drug variants not containing GLYCERYL CAPRYLATE/CAPRATE
Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE
emtricitabine and tenofovir disoproxil fumarate drug variants containing GLYCERYL MONOCAPRYLOCAPRATE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing GLYCERYL MONOCAPRYLOCAPRATE
Excipient focus: HYPROMELLOSE
emtricitabine and tenofovir disoproxil fumarate drug variants containing HYPROMELLOSE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
emtricitabine and tenofovir disoproxil fumarate drug variants containing HYPROMELLOSE 2910
emtricitabine and tenofovir disoproxil fumarate drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
emtricitabine and tenofovir disoproxil fumarate drug variants containing HYPROMELLOSES
emtricitabine and tenofovir disoproxil fumarate drug variants not containing HYPROMELLOSES
Excipient focus: KAOLIN
emtricitabine and tenofovir disoproxil fumarate drug variants containing KAOLIN
emtricitabine and tenofovir disoproxil fumarate drug variants not containing KAOLIN
Excipient focus: LACTOSE MONOHYDRATE
emtricitabine and tenofovir disoproxil fumarate drug variants containing LACTOSE MONOHYDRATE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
emtricitabine and tenofovir disoproxil fumarate drug variants containing MAGNESIUM STEARATE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
emtricitabine and tenofovir disoproxil fumarate drug variants containing MANNITOL
emtricitabine and tenofovir disoproxil fumarate drug variants not containing MANNITOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
emtricitabine and tenofovir disoproxil fumarate drug variants containing MICROCRYSTALLINE CELLULOSE 101
emtricitabine and tenofovir disoproxil fumarate drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
emtricitabine and tenofovir disoproxil fumarate drug variants containing MICROCRYSTALLINE CELLULOSE 102
emtricitabine and tenofovir disoproxil fumarate drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: MICROCRYSTALLINE CELLULOSE 112
emtricitabine and tenofovir disoproxil fumarate drug variants containing MICROCRYSTALLINE CELLULOSE 112
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | emtricitabine and tenofovir disoproxil fumarate | 0378-1930 |
| >Company | >Ingredient | >NDC |
emtricitabine and tenofovir disoproxil fumarate drug variants not containing MICROCRYSTALLINE CELLULOSE 112
Excipient focus: MICROCRYSTALLINE CELLULOSE 200
emtricitabine and tenofovir disoproxil fumarate drug variants containing MICROCRYSTALLINE CELLULOSE 200
emtricitabine and tenofovir disoproxil fumarate drug variants not containing MICROCRYSTALLINE CELLULOSE 200
Excipient focus: POLYETHYLENE GLYCOL
emtricitabine and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL
emtricitabine and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
emtricitabine and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL 400
emtricitabine and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
emtricitabine and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | emtricitabine and tenofovir disoproxil fumarate | 60505-4202 |
| >Company | >Ingredient | >NDC |
emtricitabine and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
emtricitabine and tenofovir disoproxil fumarate drug variants containing POLYVINYL ALCOHOL
emtricitabine and tenofovir disoproxil fumarate drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE K30
emtricitabine and tenofovir disoproxil fumarate drug variants containing POVIDONE K30
emtricitabine and tenofovir disoproxil fumarate drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
emtricitabine and tenofovir disoproxil fumarate drug variants containing SILICON DIOXIDE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
emtricitabine and tenofovir disoproxil fumarate drug variants containing SODIUM LAURYL SULFATE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STEARYL FUMARATE
emtricitabine and tenofovir disoproxil fumarate drug variants containing SODIUM STEARYL FUMARATE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
emtricitabine and tenofovir disoproxil fumarate drug variants containing STARCH, CORN
emtricitabine and tenofovir disoproxil fumarate drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
emtricitabine and tenofovir disoproxil fumarate drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | emtricitabine and tenofovir disoproxil fumarate | 69097-209 |
| >Company | >Ingredient | >NDC |
emtricitabine and tenofovir disoproxil fumarate drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: TALC
emtricitabine and tenofovir disoproxil fumarate drug variants containing TALC
emtricitabine and tenofovir disoproxil fumarate drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
emtricitabine and tenofovir disoproxil fumarate drug variants containing TITANIUM DIOXIDE
emtricitabine and tenofovir disoproxil fumarate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
emtricitabine and tenofovir disoproxil fumarate drug variants containing TRIACETIN
emtricitabine and tenofovir disoproxil fumarate drug variants not containing TRIACETIN
Excipient focus: WATER
emtricitabine and tenofovir disoproxil fumarate drug variants containing WATER
emtricitabine and tenofovir disoproxil fumarate drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
